NCT02791243View on ClinicalTrials.gov

Photosensitization Study in Androgenetic Alopecia

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 9, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 27, 2016

Conditions
Androgenetic Alopecia
Interventions
DRUG

Finasteride 0.25%

Cutaneous solution of finasteride 0.25%

DRUG

Placebo for Finasteride 0.25%

vehicle cutaneous solution of P-3074

DRUG

Negative Control

0.9% aqueous NaCl

Trial Locations (1)

CM2 6UA

Princeton Consumer Research Inc., Chelmsford

All Listed Sponsors
lead

Polichem S.A.

INDUSTRY

NCT02791243 - Photosensitization Study in Androgenetic Alopecia | Biotech Hunter | Biotech Hunter